5 Einträge gefunden

1. Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

   1. Mai, Elias K
   2. Huhn, Stefanie
   3. Miah, Kaya
   4. Poos, Alexandra M
   5. Scheid, Christof
   6. Weisel, Katja C
   7. Bertsch, Uta

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

   1. Mai, Elias K
   2. Miah, Kaya
   3. Bertsch, Uta
   4. Dürig, Jan
   5. Scheid, Christof
   6. Weisel, Katja C
   7. Kunz, Christina

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma

   1. Salwender, Hans
   2. Bertsch, Uta
   3. Weisel, Katja
   4. Duerig, Jan
   5. Kunz, Christina
   6. Benner, Axel
   7. Blau, Igor W

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma

   1. Merz, Maximilian
   2. Hielscher, Thomas
   3. Mai, Elias Karl
   4. Seckinger, Anja
   5. Hose, Dirk
   6. Jauch, Anna
   7. Sauer, Sandra

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
5. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.

   1. Rawstron, Andy C
   2. Orfao, Alberto
   3. Beksac, Meral
   4. Bezdickova, Ludmila
   5. Brooimans, Rik A
   6. Bumbea, Horia
   7. Dalva, Klara

   2008 - Forschungsinformationssystem des UKE - frei zugänglich